|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
|
31054894 |
2019 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
Biomarker
|
disease |
BEFREE |
In 14 CD23 negative cases IGH/BCL1 FISH detected t(11;14) and was confirmed to be mantle cell lymphoma.
|
16487171 |
2006 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
Biomarker
|
disease |
BEFREE |
On the basis of different expression patterns, we identified four diagnostic clusters (C) characterized by distinct clinico-biological features and different prognoses: C1 (149 patients) identified most classical B cell chronic lymphocytic leukemias (CLL-type cluster; SIg(dim)/CD5+/CD23+); C2, 38 patients whose clinico-hematological characteristics were intermediate between C1 and C3 (CLL-variant cluster; SIg(bright)/CD5+/CD23+/-or SIg(dim)/CD5-/-/CD23 indifferent); C3 (16 patients) most situations consistent with mantle cell lymphoma in leukemic phase (MCL-type cluster; SIg(bright)/CD5+/CD23-); and C4, 55 cases, most of whom were consistent with leukemic phase lymphoplasmacytic/splenic marginal zone lymphomas (LP/S-type cluster; SIg(bright)/CD5-/+/CD23 indifferent).
|
12529669 |
2003 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Guess what: Chronic 13q14.3+/CD5-/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23- mantle cell lymphoma in lymph nodes!
|
12500296 |
2003 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
Quantitative analysis of Cyclin D1 and CD23 expression in mantle cell lymphoma and B-chronic lymphocytic leukemia.
|
12127555 |
2002 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
The cells show surface Ig (usually IgM), B-cell-associated antigens and display the CD5-, CD23- and CD10- phenotype, which allows for differential diagnosis from B-CLL and mantle cell lymphoma. t(9;14)(p13;q32) chromosomal translocation has been found in 50% of all LPL cases.
|
11718214 |
2001 |
|
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
In both cases, immunohistochemistry (CD20+, CD5+, cyclin D1+, CD10-, and CD23-), and demonstration of clonal immunoglobulin heavy chain and bcl-1 gene rearrangements by PCR analysis confirmed the diagnosis of mantle cell lymphoma.
|
11504842 |
2001 |